The bill to legalize abortions in medical emergencies and other limited circumstances faced its first procedural hurdle in a House subcommittee.

It won’t be the last.

The suit claims that the Food and Drug Administration lacked the authority to approve mifepristone, did not adequately study it and that the drug is unsafe.

Ohio has funneled nearly $14 million in taxpayer funds to the center and others like it over the last decade, according to government records -- even as state leaders have cut funding that previously went to Planned Parenthood.